糖尿病,甲福明的使用和食道癌的存活率:基于人口的队列研究
Qiao-Li Wang1,2, Giola Santoni1, Jesper Lagergren1,3
1Upper Gastrointestinal Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
JNCI cancer spectrum
|June 14, 2023
概括
糖尿病增加了食道癌死亡率,但使用甲福林可能会降低. 需要进一步的研究来证实甲胺.
科学领域:
- 在瘤学瘤学.
- 内分泌学 在内分泌学.
- 药学流行病学 药学流行病学
背景情况:
- 糖尿病,甲胺和食道癌存活率之间的关系尚未得到充分理解.
- 食道癌带来了显著的死亡风险,受各种患者因素的影响.
研究的目的:
- 调查糖尿病和甲福明使用与食道癌患者的存活率之间的关联.
- 为了比较甲福明与其他抗糖尿病药物对食道癌死亡率的影响.
主要方法:
- 在瑞典 (2006-2019) 的食道癌新病例的基于人口的队列研究.
- 使用多变量考克斯回归分析来评估全因和疾病特异性死亡率.
- 根据年龄,性别,肥胖,并发症和其他药物使用情况进行了调整.
主要成果:
- 糖尿病与食道癌患者全因死亡率的增加有关.
- 甲胺使用与全因死亡率 (HR=0.86) 和特定疾病死亡率的降低有关.
- 对于硫尿素,胰岛素或 thiazolidinedione,没有发现显著的死亡相关性.
结论:
- 梅特福林的使用可能会改善食道癌症患者的生存结果.
- 需要进一步的研究来确定甲胺在食道癌存活率中的作用.
相关概念视频
Oral Hypoglycemic Agents: Biguanides and Glitazones
240
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
240
Cancer Survival Analysis
402
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
402
Diabetes Mellitus: Type 2 and Gestational
2.6K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.6K


